NO308901B1 - Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen - Google Patents
Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsenInfo
- Publication number
- NO308901B1 NO308901B1 NO975704A NO975704A NO308901B1 NO 308901 B1 NO308901 B1 NO 308901B1 NO 975704 A NO975704 A NO 975704A NO 975704 A NO975704 A NO 975704A NO 308901 B1 NO308901 B1 NO 308901B1
- Authority
- NO
- Norway
- Prior art keywords
- compound
- heptan
- azabicyclo
- propynyl
- methoxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/474,622 US5534522A (en) | 1995-06-07 | 1995-06-07 | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
PCT/US1996/006814 WO1996040687A1 (en) | 1995-06-07 | 1996-05-13 | (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent |
Publications (3)
Publication Number | Publication Date |
---|---|
NO975704D0 NO975704D0 (no) | 1997-12-05 |
NO975704L NO975704L (no) | 1998-01-30 |
NO308901B1 true NO308901B1 (no) | 2000-11-13 |
Family
ID=23884337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975704A NO308901B1 (no) | 1995-06-07 | 1997-12-05 | Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen |
Country Status (25)
Country | Link |
---|---|
US (1) | US5534522A (ru) |
EP (1) | EP0839148B1 (ru) |
JP (1) | JPH11506723A (ru) |
KR (1) | KR100383031B1 (ru) |
CN (1) | CN1063181C (ru) |
AT (1) | ATE187967T1 (ru) |
BG (1) | BG63571B1 (ru) |
CA (1) | CA2219753A1 (ru) |
CZ (1) | CZ286528B6 (ru) |
DE (1) | DE69605800T2 (ru) |
DK (1) | DK0839148T3 (ru) |
EA (1) | EA000381B1 (ru) |
EE (1) | EE03971B1 (ru) |
ES (1) | ES2142586T3 (ru) |
GE (1) | GEP19991874B (ru) |
GR (1) | GR3032772T3 (ru) |
HK (1) | HK1018055A1 (ru) |
HU (1) | HUP9802499A3 (ru) |
NO (1) | NO308901B1 (ru) |
NZ (1) | NZ307946A (ru) |
PL (1) | PL323796A1 (ru) |
SK (1) | SK282824B6 (ru) |
UA (1) | UA46032C2 (ru) |
WO (1) | WO1996040687A1 (ru) |
ZA (1) | ZA964764B (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9601909A (pt) * | 1995-07-13 | 1999-10-13 | Smithkline Beecham Corp | N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
KR20060058728A (ko) * | 2003-10-02 | 2006-05-30 | 파마시아 앤드 업존 캄파니 엘엘씨 | 피롤-치환된 인돌리논 화합물의 염 및 다형체 |
US7741358B2 (en) * | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
ES2400772T3 (es) * | 2005-06-07 | 2013-04-12 | Ramot At Tel Aviv University Ltd. | Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5ht受容体介在性の神経新生 |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2051735B1 (en) | 2006-07-17 | 2012-08-29 | Ramot, at Tel Aviv University Ltd. | Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US8207369B2 (en) | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US8975251B2 (en) | 2009-12-09 | 2015-03-10 | Bar-Ilan University | Methods of improving cognitive functions |
CA2789654A1 (en) | 2010-02-24 | 2011-09-01 | Ramot At Tel-Aviv University Ltd. | Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
US8916610B2 (en) | 2010-09-22 | 2014-12-23 | Ramot At Tel-Aviv University Ltd. | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same |
JP5997931B2 (ja) * | 2011-05-25 | 2016-09-28 | 石原産業株式会社 | 農園芸用殺菌剤組成物及び植物病害の防除方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5346911A (en) * | 1990-03-06 | 1994-09-13 | Warner-Lambert Company | Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
US5306718A (en) * | 1990-03-06 | 1994-04-26 | Warner-Lambert Company | Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment |
-
1995
- 1995-06-07 US US08/474,622 patent/US5534522A/en not_active Expired - Fee Related
-
1996
- 1996-05-13 EE EE9700316A patent/EE03971B1/xx not_active IP Right Cessation
- 1996-05-13 AT AT96915757T patent/ATE187967T1/de not_active IP Right Cessation
- 1996-05-13 PL PL96323796A patent/PL323796A1/xx unknown
- 1996-05-13 KR KR1019970709053A patent/KR100383031B1/ko not_active IP Right Cessation
- 1996-05-13 CZ CZ19973817A patent/CZ286528B6/cs not_active IP Right Cessation
- 1996-05-13 HU HU9802499A patent/HUP9802499A3/hu unknown
- 1996-05-13 SK SK1644-97A patent/SK282824B6/sk unknown
- 1996-05-13 CA CA002219753A patent/CA2219753A1/en not_active Abandoned
- 1996-05-13 UA UA98010040A patent/UA46032C2/uk unknown
- 1996-05-13 EP EP96915757A patent/EP0839148B1/en not_active Expired - Lifetime
- 1996-05-13 CN CN96194436A patent/CN1063181C/zh not_active Expired - Fee Related
- 1996-05-13 WO PCT/US1996/006814 patent/WO1996040687A1/en active IP Right Grant
- 1996-05-13 JP JP9500555A patent/JPH11506723A/ja active Pending
- 1996-05-13 EA EA199800007A patent/EA000381B1/ru not_active IP Right Cessation
- 1996-05-13 ES ES96915757T patent/ES2142586T3/es not_active Expired - Lifetime
- 1996-05-13 DK DK96915757T patent/DK0839148T3/da active
- 1996-05-13 GE GEAP19964088A patent/GEP19991874B/en unknown
- 1996-05-13 NZ NZ307946A patent/NZ307946A/en unknown
- 1996-05-13 DE DE69605800T patent/DE69605800T2/de not_active Expired - Fee Related
- 1996-06-06 ZA ZA964764A patent/ZA964764B/xx unknown
-
1997
- 1997-11-27 BG BG102078A patent/BG63571B1/bg unknown
- 1997-12-05 NO NO975704A patent/NO308901B1/no not_active IP Right Cessation
-
1998
- 1998-12-15 HK HK98113383A patent/HK1018055A1/xx not_active IP Right Cessation
-
2000
- 2000-02-28 GR GR20000400474T patent/GR3032772T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308901B1 (no) | Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen | |
LU92132I2 (fr) | Sel d'aclidinium avec anion d'un acide mono ou polyvalent pharmaceutiquement acceptable particulièrement le bromure d'aclidinium | |
CA2149242A1 (en) | Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders | |
EP0398629A3 (en) | An oxadiazole and its salts, their use in treating dementia, their preparation and formulations | |
EP0852117A4 (en) | IMPROVEMENT OF LIPID METABOLISM | |
CA2246839A1 (en) | Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy | |
CA2176298A1 (en) | A single high dose fluoroquinolone treatment | |
CA2155323A1 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
EP0214557A3 (en) | Use of serotonin antagonists, particularly cyproheptadine, in the treatment of cancer, alzheimer's disease, aids and multiple sclerosis | |
CA2300289A1 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
CA2220019A1 (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
HU900255D0 (en) | Process for preparation of 3-phenyl-5,6-dilhydrobenz (c)-acridine-carboxylic-acids and carboxylic-acid derivatives and for manufacturing of pharmaceutical composition containing these compounds as active ingredient | |
IT8022843A0 (it) | Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1.chiusa par.quadrata-ottan-3-alchilcarbossilati , processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo. | |
MX9708337A (es) | Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico. | |
CA2189762A1 (en) | Use of no scavengers, inhibitors or antagonists in the treatment of migraine | |
NO175565C (no) | Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid | |
MY115734A (en) | Resolution of 1-azabicyclo (2.2.2.) octon -3-amine, 2-(diphenylmethyl)-n- [[2-methoxy-5-(1-mehtylethyl) phenyl]methyl] | |
IE890232L (en) | Condensed diazepinones | |
CA2222552A1 (en) | N-oxides as antibacterial agents | |
BR9808428A (pt) | Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida | |
AU3978095A (en) | Heterocyclic compounds and their preparation and use | |
EP0318166A3 (en) | Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
EP0396169A3 (en) | Pharmaceutical composition for topical ophthalmic use having improved local tolerability | |
Takayanagi et al. | A new parasympathomimetic agent: 1-methyl-5-chloroindoline methylbromide | |
CA2053346A1 (en) | Microcapsule compositions for torical treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |